Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

ICE regimen

View Patient Information
A regimen consisting of carboplatin, etoposide and ifosfamide that can be used in the treatment of non-Hodgkin and Hodgkin lymphomas, including diffuse large B-cell lymphoma and T-cell lymphoma, mycosis fungoides/Sezary syndrome, and gestational trophoblastic neoplasia. Paclitaxel/carboplatin/oral etoposide regimen can be used for the treatment of occult primary adenocarcinoma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:carboplatin/etoposide/ifosfamide
ifosfamide-carboplatin-etoposide regimen
ifosfamide/carboplatin/etoposide
ifosfamide/carboplatin/etoposide
iosfamide-carboplatin-etoposide regimen
Abbreviation:CBDCA/IFF/VP-16
Acronym:ICE
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search